- Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma. Elson, P.J., Kvols, L.K., Vogl, S.E., Glover, D.J., Hahn, R.G., Trump, D.L., Carbone, P.P., Earle, J.D., Davis, T.E. Investigational new drugs. (1988)









